Sophia Genetics Q3 2024 GAAP EPS $(0.28) Misses $(0.22) Estimate, Sales $15.853M Beat $15.850M Estimate
Sophia Genetics Q3 2024 GAAP EPS $(0.28) Misses $(0.22) Estimate, Sales $15.853M Beat $15.850M Estimate
Sophia遗传学2024年第3季度的普通股每股收益为$(0.28)，低于$(0.22)的预估，销售额为1585.3万元，高于1585万元的预估
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.22) by 27.27 percent. This is a 33.33 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $15.853 million which beat the analyst consensus estimate of $15.850 million by 0.02 percent. This is a 2.76 percent decrease over sales of $16.303 million the same period last year.
Sophia Genetics（纳斯达克股票代码：SOPH）每股报告亏损$(0.28)，较分析师共识预期$(0.22)低27.27%。这较去年同期每股亏损$(0.21)减少33.33%。公司季度销售额达到1585.3万美元，高于分析师共识预期的1585万美元0.02%。这较去年同期的1630.3万美元销售额下降2.76%。
资讯热榜
更新时间